Patent Assignment
Reel/Frame 019375/0493
Assignment of Assignor's Interest
Recorded: 2007-06-04
Pages: 26
Assignor
PLATT, DAVID
Executed: 2003-08-27
Assignee
GLYCOGENESYS, INC.
31 ST. JAMES AVE, BOSTON, MASSACHUSETTS, 02116
Covered Properties
(2)
Delivery of a Therapeutic Agent in a Formulation for Reduced Toxicity
Delivery of a Therapeutic Agent in a Formulation for Reduced Toxicity
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 1, 2007
From: KLYOSOV, ANATOLE, DR.; PLATT, DAVID, DR.
To: PRO-PHARMACEUTICALS, INC
Reel/Frame 018942/0817 →
Assignment of Assignor's Interest
Mar 1, 2007
From: KLYOSOV, ANATOLE, DR.; PLATT, DAVID, DR.
To: PRO-PHARMACEUTICALS, INC.
Reel/Frame 018942/0833 →
Change of Name
Jun 4, 2007
From: PROSPECT PHARMACEUTICALS, INC.
To: PROSPECT THERAPEUTICS, INC.
Reel/Frame 019365/0638 →
Court Appointment of Trustee
Jun 4, 2007
From: GLYCOGENESYS, INC.
To: MARK G. DEGIACOMO, CHAPTER 7 TRUSTEE OF GLYCOGENESYS, INC.
Reel/Frame 019365/0501 →
Assignment of Claims
Jun 4, 2007
From: MARK G. DEGIACOMO, CHAPTER 7 TRUSTEE OF GLYCOGENESYS, INC.
To: MARLBOROUGH RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 019365/0510 →
Change of Name
Jun 4, 2007
From: MARLBOROUGH RESEARCH AND DEVELOPMENT, INC.
To: PROSPECT PHARMACEUTICALS, INC.
Reel/Frame 019365/0633 →
Security Agreement
Aug 26, 2009
From: PRO-PHARMACEUTICALS, INC.
To: 10X FUND, LP
Reel/Frame 023134/0968 →
Change of Name
Oct 18, 2012
From: PRO-PHARMACEUTICALS, INC.
To: GALECTIN THERAPEUTICS INC.
Reel/Frame 029150/0654 →
Release of Security Interest
Sep 17, 2019
From: 10X FUND L.P.
To: GALECTIN THERAPEUTICS, INC.
Reel/Frame 050399/0679 →